Skip to content
OpenCapital
Get started

Merit Medical Systems MMSI Cash & Equivalents

Cash & Equivalents at other companies

Abbott logo
AbbottABT
$6.8B+4.1%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$1.02B+49.0%
TFX
TeleflexTFX
$329.55M+16.8%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$21.69B-43.6%
Stryker logo
StrykerSYK
$2.88B+24.1%
Boston Scientific logo
Boston ScientificBSX
$850M+146%

Other financials

Income statement

See full
Revenue$381.9M+7.5%
Gross profit$184.8M+7.4%
Operating income$44.2M+7.6%
Net income$41.0M+36.0%
EPS (diluted)$0.68+38.8%

Balance sheet

See full
Total debt$821.6M+0.5%
Total equity$1.6B+13.9%
Total assets$2.7B+10.2%

Cash flow

See full
Operating cash flow$40.7M+0.3%
CapEx$16.0M-24.0%
Free cash flow$24.7M+26.5%

Valuation

See full
Market cap$4.01B-34.1%
Enterprise value$4.34B-33.3%
P/E28.8×-21.0×
P/S2.6×-1.8×

Profitability

See full
Gross margin48.7%+0.9pp
Operating margin12.2%+0.6pp
Net margin9%+0.2pp
FCF margin14.3%+1.3pp

Returns & leverage

See full
Return on equity9.1%0.0pp
Debt / equity0.5×-0.1×
Current ratio5.1×+0.2×

Where this comes from

Reported directly by Merit Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: Merit Medical Systems’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merit Medical Systems's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Merit Medical Systems's cash & equivalents?
Merit Medical Systems (MMSI) reported cash & equivalents of $488.08M in Q1 2026.
How has Merit Medical Systems's cash & equivalents changed year-over-year?
Merit Medical Systems's cash & equivalents increased by 23.4% year-over-year, from $395.53M to $488.08M.
What is the long-term trend for Merit Medical Systems's cash & equivalents?
Over 5 years (2020 to 2025), Merit Medical Systems's cash & equivalents has grown at a 51.0% compound annual growth rate (CAGR), from $56.92M to $446.4M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.